Performance and Safety Evaluation of the FHK®-CK Knee Prosthesis

Last updated: June 16, 2025
Sponsor: FH ORTHO
Overall Status: Active - Recruiting

Phase

N/A

Condition

Knee Replacement

Treatment

Total Knee arthroplasty

Clinical Study ID

NCT06124482
2022-01
  • Ages > 18
  • All Genders

Study Summary

The life expectancy worldwide is increasing and leading to an increase of knee arthroplasty. Also, as millions of people around the world are currently living with a Total Knee Arthroplasty (TKA), the need for revision surgery represents a large public health burden. In this context, FH ORTHO company develops FHK®-CK (prosthesis + ancillary equipment) which is a knee prosthesis for complex first intention and revision knee arthroplasty. This new medical device complements the FHK® standard first-line range (CE marked).

The FHK®-CK ancillary equipment were designed by expert knee surgeons and is simple, reliable and reproducible. It allows for maximum versatility while remaining compact.

By completing the FHK® range of first intention prostheses, the FHK®-CK allows the surgeon to be on the same level as the competitors by having a first intention and semi-constrained prosthesis. This prosthetic arsenal allows the surgeon to opt for the best solution for his patient so that he can regain mobility and a satisfactory quality of life. Also, in case of failure of the FHK® first-line prosthesis, it will provide the surgeon and the patient with a simple alternative to prosthesis replacement. As it has been developed in line with the first intention, inter-compatibility between the two systems is possible, which simplifies the surgical procedure and reduces the risks for the patient.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Patient requiring knee arthroplasty for primary or secondary gonarthrosis:
  • For primary intention arthroplasty: Patient with either
  • major axial deviation,

  • major peripheral failure or

  • bone defect;

  • For prosthesis revision surgery: Patient who have had a failed 1stimplantation, with or without bone defects.
  • Patient able to understand and answer the questionnaires provided by the protocol;

  • Subject affiliated to a health insurance system or is a beneficiary;

  • Signed informed consent form (ICF) for participation to the research.

Exclusion

Exclusion Criteria:

  • Patient with an ongoing acute infection, outside knee to be operated;

  • Patient with a mental or neuromuscular disorder that would create an unacceptablerisk of prosthetic instability, prosthetic fixation failure or post-operativecomplications;

  • Patient with a known allergy to any of the components of the FHK®-CK implants (Nickel, Cobalt, Chromium);

  • Patient with a dependency (drug, alcohol,...) that could affect his/ her ability tocomply with the protocol, at the investigator's discretion;

  • Patient requiring knee reconstruction;

  • Patient with any medically significant findings or significant history that mayimpact the safety, interpretation of results, and/ or participation of the subjectin the clinical trial, as determined by the investigator;

  • Patient with an existing knee or hip prosthesis (outside knee to be operated) thatmay impact the evaluation of the FHK®-CK prosthesis;

  • Patient concurrently participating in another clinical trial or who has recentlyparticipated in another clinical trial for which the exclusion period has not beencompleted.

  • Vulnerable subjects :

  • Pregnant, parturient, or breastfeeding women,

  • Subject deprived of liberty, hospitalized without consent or admitted to ahealth or social establishment for purposes other than that of research,

  • Minor,

  • Adult under protective supervision (tutorship, curatorship),

  • Subject not able to understand the subject information leaflet (e.g. forlinguistic or psychiatric reasons) and/or to give informed consent

Study Design

Total Participants: 92
Treatment Group(s): 1
Primary Treatment: Total Knee arthroplasty
Phase:
Study Start date:
February 01, 2024
Estimated Completion Date:
February 29, 2028

Connect with a study center

  • Hôpital Privé La Châtaigneraie

    Beaumont, 63110
    France

    Terminated

  • CHRU de la Cavale Blanche

    Brest, 29200
    France

    Active - Recruiting

  • Hôpital Beaujon AP-HP

    Clichy, 92110
    France

    Active - Recruiting

  • Hôpital Raymond Poincaré AP-HP

    Garches, 92380
    France

    Active - Recruiting

  • CH d'Haguenau

    Haguenau, 67500
    France

    Active - Recruiting

  • Centre Hospitalier Régional Universitaire de Nancy

    Nancy, 54000
    France

    Active - Recruiting

  • Groupe Hospitalier Pitié Salpêtrière AP-HP

    Paris, 75013
    France

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.